UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 210

Sortiert nach

Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease

Brain research, 2010-11, Vol.1362 (1362), p.13-22

2010

Volltextzugriff (PDF)

Fluid‐based proteomics targeted on pathophysiological processes and pathologies in neurodegenerative diseases

Journal of neurochemistry, 2019-11, Vol.151 (4), p.417-434

2019

Volltextzugriff (PDF)

Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer's disease

Alzheimer's & dementia : diagnosis, assessment & disease monitoring, 2021, Vol.13 (1), p.e12179-n/a

2021

Volltextzugriff (PDF)

Comprehensive Quantitative Profiling of Tau and Phosphorylated Tau Peptides in Cerebrospinal Fluid by Mass Spectrometry Provides New Biomarker Candidates

Journal of Alzheimer's disease, 2017-01, Vol.55 (1), p.303

2017

Volltextzugriff (PDF)

Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer's disease continuum

Molecular neurodegeneration, 2022-12, Vol.17 (1), p.81-14, Article 81

2022

Volltextzugriff (PDF)

Peptidome analysis of cerebrospinal fluid by LC-MALDI MS

PloS one, 2012-08, Vol.7 (8), p.e42555-e42555

2012

Volltextzugriff (PDF)

Harmonization and standardization of biofluid-based biomarker measurements for AT(N) classification in Alzheimer's disease

Alzheimer's & dementia : diagnosis, assessment & disease monitoring, 2023-07, Vol.15 (3), p.e12465-e12465

2023

Volltextzugriff (PDF)

Levels of ADAM10 are reduced in Alzheimer's disease CSF

Journal of neuroinflammation, 2018-07, Vol.15 (1), p.213-213, Article 213

2018

Volltextzugriff (PDF)

Exhaled Endogenous Particles Contain Lung Proteins

Clinical chemistry (Baltimore, Md.), 2012-02, Vol.58 (2), p.431-440

2012

Volltextzugriff (PDF)

A selected reaction monitoring (SRM)-based method for absolute quantification of Aβ38, Aβ40, and Aβ42 in cerebrospinal fluid of Alzheimer's disease patients and healthy controls

Journal of Alzheimer's disease, 2013-01, Vol.33 (4), p.1021

2013

Volltextzugriff (PDF)

Identification of a Chlorobenzene Reductive Dehalogenase in Dehalococcoides sp. Strain CBDB1

Applied and Environmental Microbiology, 2007-12, Vol.73 (23), p.7717-7724

2007

Volltextzugriff (PDF)

Neuroligin-1 in brain and CSF of neurodegenerative disorders: investigation for synaptic biomarkers

Acta neuropathologica communications, 2021-02, Vol.9 (1), p.19-19, Article 19

2021

Volltextzugriff (PDF)

Regulation of muscle development by DPF3, a novel histone acetylation and methylation reader of the BAF chromatin remodeling complex

Genes & development, 2008-09, Vol.22 (17), p.2370-2384

2008

Volltextzugriff (PDF)

Novel cerebrospinal fluid biomarkers correlating with shunt responsiveness in patients with idiopathic normal pressure hydrocephalus

Fluids and barriers of the CNS, 2023-06, Vol.20 (1), p.40-16, Article 40

2023

Volltextzugriff (PDF)

Tau protein profiling in tauopathies: a human brain study

Molecular neurodegeneration, 2024-07, Vol.19 (1), p.54-25, Article 54

2024

Volltextzugriff (PDF)

Proteomic and functional analysis of the mitotic Drosophila centrosome

The EMBO journal, 2010-10, Vol.29 (19), p.3344-3357

2010

Volltextzugriff (PDF)

Comparison of immunoassay- with mass spectrometry-derived p-tau quantification for the detection of Alzheimer's disease pathology

Molecular neurodegeneration, 2024-01, Vol.19 (1), p.2-2, Article 2

2024

Volltextzugriff (PDF)

Quantification of SNAP-25 with mass spectrometry and Simoa: a method comparison in Alzheimer's disease

Alzheimer's research & therapy, 2022-06, Vol.14 (1), p.78-78, Article 78

2022

Volltextzugriff (PDF)

Pathophysiological subtypes of mild cognitive impairment due to Alzheimer's disease identified by CSF proteomics

Translational neurodegeneration, 2024-04, Vol.13 (1), p.19-19, Article 19

2024

Volltextzugriff (PDF)

Mass-spectrometric identification of a novel angiotensin peptide in human plasma

Arteriosclerosis, thrombosis, and vascular biology, 2007-02, Vol.27 (2), p.297

2007

Volltextzugriff (PDF)

Sample purification and preparation technique based on nano-scale reversed-phase columns for the sensitive analysis of complex peptide mixtures by matrix-assisted laser desorption/ionization mass spectrometry

Journal of mass spectrometry., 1999-02, Vol.34 (2), p.105-116

1999

Volltextzugriff (PDF)

Differential Stimulation of Pluripotent Stem Cell-Derived Human Microglia Leads to Exosomal Proteomic Changes Affecting Neurons

Cells (Basel, Switzerland), 2021-10, Vol.10 (11), p.2866

2021

Volltextzugriff (PDF)

Corrigendum to “Use of the tau protein-to-peptide ratio in CSF to improve diagnostic classification of Alzheimer’s disease” [Clin. Mass Spectrom. 14 (Part B) (2019) 74–82]

Journal of mass spectrometry and advances in the clinical lab, 2022-11, Vol.26, p.35-35

2022

Volltextzugriff (PDF)

High heterogeneity within the ribosomal proteins of the Arabidopsis thaliana 80S ribosome

Plant molecular biology, 2005-03, Vol.57 (4), p.577-591

2005

Volltextzugriff (PDF)

Functional Analysis of Centrosomal Kinase Substrates in Drosophila melanogaster Reveals a New Function of the Nuclear Envelope Component Otefin in Cell Cycle Progression

Molecular and Cellular Biology, 2012-09, Vol.32 (17), p.3554-3569

2012

Volltextzugriff (PDF)

1 – 25 von 210

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(209)
Mit Volltextzugriff
(193)

Publikationsform

Artikel
(209)
Tagungsberichte
(1)

Sprache

Englisch
(210)
Japanisch
(19)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease

Fluid‐based proteomics targeted on pathophysiological processes and pathologies in neurodegenerative diseases

Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer's disease

Comprehensive Quantitative Profiling of Tau and Phosphorylated Tau Peptides in Cerebrospinal Fluid by Mass Spectrometry Provides New Biomarker Candidates

Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer's disease continuum

Peptidome analysis of cerebrospinal fluid by LC-MALDI MS

Harmonization and standardization of biofluid-based biomarker measurements for AT(N) classification in Alzheimer's disease

Levels of ADAM10 are reduced in Alzheimer's disease CSF

Exhaled Endogenous Particles Contain Lung Proteins

A selected reaction monitoring (SRM)-based method for absolute quantification of Aβ38, Aβ40, and Aβ42 in cerebrospinal fluid of Alzheimer's disease patients and healthy controls

Identification of a Chlorobenzene Reductive Dehalogenase in Dehalococcoides sp. Strain CBDB1

Neuroligin-1 in brain and CSF of neurodegenerative disorders: investigation for synaptic biomarkers

Regulation of muscle development by DPF3, a novel histone acetylation and methylation reader of the BAF chromatin remodeling complex

Novel cerebrospinal fluid biomarkers correlating with shunt responsiveness in patients with idiopathic normal pressure hydrocephalus

Tau protein profiling in tauopathies: a human brain study

Proteomic and functional analysis of the mitotic Drosophila centrosome

Comparison of immunoassay- with mass spectrometry-derived p-tau quantification for the detection of Alzheimer's disease pathology

Quantification of SNAP-25 with mass spectrometry and Simoa: a method comparison in Alzheimer's disease

Pathophysiological subtypes of mild cognitive impairment due to Alzheimer's disease identified by CSF proteomics

Mass-spectrometric identification of a novel angiotensin peptide in human plasma

Sample purification and preparation technique based on nano-scale reversed-phase columns for the sensitive analysis of complex peptide mixtures by matrix-assisted laser desorption/ionization mass spectrometry

Differential Stimulation of Pluripotent Stem Cell-Derived Human Microglia Leads to Exosomal Proteomic Changes Affecting Neurons

Corrigendum to “Use of the tau protein-to-peptide ratio in CSF to improve diagnostic classification of Alzheimer’s disease” [Clin. Mass Spectrom. 14 (Part B) (2019) 74–82]

High heterogeneity within the ribosomal proteins of the Arabidopsis thaliana 80S ribosome

Functional Analysis of Centrosomal Kinase Substrates in Drosophila melanogaster Reveals a New Function of the Nuclear Envelope Component Otefin in Cell Cycle Progression

Suchergebnisse filtern